Literature DB >> 3486068

Difference in the biological properties of the two forms of the fourth component of human complement (C4).

J A Schifferli, G Steiger, J P Paccaud, A G Sjöholm, G Hauptmann.   

Abstract

The two forms of human C4 were compared in their haemolytic activity and in their capacity to mediate inhibition of immune complex precipitation in human C4 deficient sera. Whereas haemolysis by C4B was 3.2 fold more efficient than by C4A, C4A was 1.7 fold more efficient at inhibiting immune precipitation than C4B. Thus the biological properties of the two forms of human C4 are different and it is suggested that C4A is mainly involved in immune complex clearance reactions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486068      PMCID: PMC1577380     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

2.  A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.

Authors:  T A Gaither; D W Alling; M M Frank
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

3.  The role of C1, C1-inactivator and C4 in modulating immune precipitation.

Authors:  J A Schifferli; G Steiger; M Schapira
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

4.  Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.

Authors:  J A Schifferli; P Woo; D K Peters
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

5.  Familial systemic lupus erythematosus and C4 deficiency.

Authors:  S Berliner; A Weinberger; R Zamir; F Salomon; H Joshua; J Pinkhas
Journal:  Scand J Rheumatol       Date:  1981       Impact factor: 3.641

6.  A molecular basis for the two locus model of human complement component C4.

Authors:  M H Roos; E Mollenhauer; P Démant; C Rittner
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

7.  Inhibition of immune precipitation by complement.

Authors:  J A Schifferli; S R Bartolotti; D K Peters
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

8.  Large scale isolation of functionally active components of the human complement system.

Authors:  C H Hammer; G H Wirtz; L Renfer; H D Gresham; B F Tack
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

9.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05
View more
  19 in total

Review 1.  The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura.

Authors:  J F Knight
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

2.  Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.

Authors:  G J Arason; R Kolka; A B Hreidarsson; H Gudjonsson; P M Schneider; L Fry; A Arnason
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

3.  The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence.

Authors:  E R Holme; J Veitch; A Johnston; I C McKay; K Whaley
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

4.  An inhibitor of complement-mediated prevention of immune precipitation in rheumatoid arthritis--relationship to disease activity and systemic manifestations.

Authors:  W S Mitchell; J Veitch; J Hunter; A Zoma; H Capell; K Whaley
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 5.  Complement activation and complement receptors in systemic lupus erythematosus.

Authors:  J P Atkinson
Journal:  Springer Semin Immunopathol       Date:  1986

6.  C4 null alleles in childhood onset systemic lupus erythematosus. Is there any relationship with renal disease?

Authors:  S Clemenceau; F Castellano; M Montes de Oca; C Kaplan; F Danon; M Levy
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

7.  Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.

Authors:  M C Carroll; D M Fathallah; L Bergamaschini; E M Alicot; D E Isenman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

8.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

Review 9.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  The complement system in type 1 (insulin-dependent) diabetes.

Authors:  J A Charlesworth; V Timmermans; J Golding; L V Campbell; P W Peake; B A Pussell; D Wakefield; N Howard
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.